Research on the CFTR gene is ongoing, with promising advancements in gene therapy, which aims to correct the defective gene itself. Scientists are also exploring the potential of CRISPR-Cas9 technology to edit and repair specific CFTR mutations. Continued research is crucial for developing more effective treatments and ultimately finding a cure for Cystic Fibrosis and other CFTR-related conditions.
